Silexion Therapeutics (SLXNW) Q1 2026 Earnings

17MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-4.32
-3.25
-2.19
-1.12

Details

Expected EPS
-1.12
Actual EPS
-2.385
Surprise EPS
-1.26
Surprise Percent
+112.95%

Description

Silexion Therapeutics (SLXNW) has reported earnings of -2.385 per share for Q1 2026.

0 Comments

Share your thoughts